2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO4] Mini-Oral Session 4　Lung Cancer / Thoracic Cancer 2（Miscellaneous）
【E】

Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Hiroyasu Kaneda（Department of Clinical Oncology, Osaka City University），Ikuo Sekine（Department of Medical Oncology, University of Tsukuba Faculty of Medicine）

[MO4-5] Safety of dosage switching of Pembrolizumab from 200mg Q3W to 400 mg Q6W in advanced NSCLC patients

○Ryoko Higashiyama1, Tatsuya Yoshida1, Shigehiro Yagisita2, Naomi Sakiyama1, Ken Masuda1, Yuki Shinno1, Yuji Matsumoto1, Yusuke Okuma1, Yasushi Goto1, Hidehito Horinouchi1, Noboru Yamamoto1, Akinobu Hamada2, Yuichiro Ohe1 (1.Department of Thoracic Oncology, National Cancer Center Hospital, Japan, 2.Division of Molecular Pharmacology, National Cancer Center Research Institute, Japan)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password